|
시장보고서
상품코드
2055267
DNA 제조 시장 : DNA 유형별, 용도별, 기술별, 등급별, 생산 규모별, 최종사용자별, 지역별DNA Manufacturing Market, By Type of DNA, By Application, By Technology, By Grade, By Production Scale, By End User, By Geography |
||||||
DNA 제조 시장은 2026년 75억 6,000만 달러로 추정되며, 2033년까지 232억 4,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 17.4%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 75억 6,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 17.40% | 2033년 시장 규모 예측 : | 232억 4,000만 달러 |
세계 DNA 제조 시장은 생명공학 산업 내에서 급속히 발전하고 있는 분야로, 제약, 연구, 진단, 치료 등 각 분야의 다양한 용도를 위한 데옥시리보핵산(DNA)의 생산, 합성 및 상업적 제조를 포괄합니다. 이 시장은 유전공학, 합성생물학 및 맞춤형 의료 분야의 전례 없는 발전에 힘입어 현대 바이오 경제의 핵심 구성 요소로 부상하고 있습니다. DNA 제조에는 고품질 DNA 구축체, 플라스미드, 올리고뉴클레오티드 및 합성 유전자를 제작하기 위한 화학 합성, 효소 생산, 바이오 제조 기술 등의 첨단 공정이 포함됩니다.
이 시장은 유전자 치료제나 백신을 개발하는 제약 기업부터 기초 유전자 연구를 수행하는 학술 연구 기관에 이르기까지 다양한 최종 사용자에게 서비스를 제공합니다. 주요 제조 공정에는 고체상 합성, PCR 증폭, 그리고 확장 가능하고 비용 효율적인 DNA 생산을 가능하게 하는 발효 기반 생산 시스템이 포함됩니다. 이 업계에서는 자동화, 품질 관리 시스템 및 정제 기술 분야에서 획기적인 기술적 진전이 이루어져 생산 효율과 제품 품질이 모두 향상되고 있습니다. 세계의 관심이 정밀 의학, CRISPR-Cas9과 같은 유전자 편집 기술, 그리고 차세대 치료제로 이동하는 가운데, DNA 제조 시장은 종양학, 희귀질환, 감염증을 포함한 여러 치료 분야에서 그 입지를 지속적으로 확대하며, 현대 생명공학 발전의 필수적인 축으로서 확고한 위치를 굳히고 있습니다.
시장 역학
세계 DNA 제조 시장은 생명공학의 전망을 근본적으로 변화시키고 전례 없는 성장 기회를 창출하고 있는 몇 가지 강력한 촉진요인에 의해 주도되고 있습니다. 주요 촉진요인은 유전자 치료 개발의 급격한 확대에 있습니다. 수많은 임상시험이 규제 당국의 심사 절차를 거쳐 미국 식품의약국(USFDA) 및 유럽의약품청(EMA) 등의 승인을 획득함에 따라, 고품질 치료용 DNA 제품에 대한 수요가 크게 증가하고 있습니다. 또한, 코로나19 팬데믹은 신속한 백신 개발과 생산 능력의 중요성을 부각시켰으며, 시장의 성장을 크게 가속화했습니다. 특히, 제조에 고도의 DNA 템플릿이나 플라스미드가 필요한 mRNA 백신의 경우, 이러한 경향이 두드러집니다. 민간 및 공공 부문의 합성생물학 및 유전공학 연구에 대한 투자 증가가 맞춤형 DNA 합성 서비스와 표준화된 DNA 구성 요소에 대한 수요를 견인하고 있습니다. 그러나 시장에는 광범위한 문서화, 품질 관리 조치, 그리고 우수 제조 기준(GMP) 준수를 요구하는 엄격한 규제 체계와 같은 뚜렷한 제약이 존재하며, 이러한 요인들은 생산 비용과 시장 출시까지의 시간을 크게 증가시키고 있습니다. 최첨단 제조 시설을 구축하는 데 필요한 막대한 설비 투자에 더해, 전문적인 숙련 인력과 첨단 설비가 요구된다는 점이 신규 시장 진출기업에게는 진입 장벽으로 작용하고 있습니다. DNA의 안정성 유지, 순도 수준 확보, 그리고 실험실 규모에서 상업 규모로의 생산 공정 확대와 관련된 기술적 과제는 여전히 운영상의 제약 요인으로 남아 있습니다. 그럼에도 불구하고, DNA 데이터 저장, 농업 생명공학, 환경 복원 등 신흥 분야에서의 DNA 응용 확대에 힘입어 시장에는 큰 기회가 존재하고 있습니다. 맞춤형 의료 접근법의 확산에 따라, 환자 맞춤형 DNA 구축체 및 맞춤형 제조 서비스에 대한 수요가 증가하고 있습니다. 자동화, 인공지능(AI)을 활용한 품질 관리, 그리고 새로운 합성 기법 분야의 기술적 진보는 비용 절감과 효율 향상을 위한 새로운 길을 열어주고 있으며, 한편 전 세계적으로 유전성 질환의 유병률이 증가하고 있어 DNA 기반 치료 솔루션의 잠재 시장은 지속적으로 확대되고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 항목(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략)을 바탕으로 전 세계 DNA 제조 시장의 주요 기업 프로파일을 소개합니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 세계 DNA 제조 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 DNA 제조 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 DNA 제조 시장 : DNA 유형별, 2021년-2033년
제5장 세계의 DNA 제조 시장 : 용도별, 2021년-2033년
제6장 세계의 DNA 제조 시장 : 기술별, 2021년-2033년
제7장 세계의 DNA 제조 시장 : 등급별, 2021년-2033년
제8장 세계의 DNA 제조 시장 : 생산 규모별, 2021년-2033년
제9장 세계의 DNA 제조 시장 : 최종사용자별, 2021년-2033년
제10장 세계의 DNA 제조 시장 : 지역별, 2021년-2033년
제11장 경쟁 구도
제12장 애널리스트의 제안
제13장 참고 문헌 및 조사 방법
LSH 26.06.23DNA Manufacturing Market is estimated to be valued at USD 7.56 Bn in 2026 and is expected to reach USD 23.24 Bn by 2033, growing at a compound annual growth rate (CAGR) of 17.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 7.56 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 17.40% | 2033 Value Projection: | USD 23.24 Bn |
The global DNA manufacturing market represents a rapidly evolving sector within the biotechnology industry, encompassing the production, synthesis, and commercial manufacturing of deoxyribonucleic acid (DNA) for various applications across pharmaceutical, research, diagnostic, and therapeutic domains. This market has emerged as a critical component of the modern bioeconomy, driven by unprecedented advances in genetic engineering, synthetic biology, and personalized medicine. DNA manufacturing involves sophisticated processes including chemical synthesis, enzymatic production, and bio-manufacturing techniques to create high-quality DNA constructs, plasmids, oligonucleotides, and synthetic genes.
The market serves diverse end users ranging from pharmaceutical companies developing gene therapies and vaccines to academic research institutions conducting fundamental genetic research. Key manufacturing processes include solid-phase synthesis, PCR amplification, and fermentation-based production systems that enable scalable and cost-effective DNA production. The industry has witnessed significant technological breakthroughs in automation, quality control systems, and purification methodologies, enhancing both production efficiency and product quality. As the global focus shifts toward precision medicine, gene editing technologies like CRISPR-Cas9, and next-generation therapeutics, the DNA manufacturing market continues to expand its footprint across multiple therapeutic areas including oncology, rare diseases, and infectious diseases, establishing itself as an indispensable pillar of modern biotechnological advancement.
Market Dynamics
The global DNA manufacturing market is propelled by several robust drivers that are fundamentally reshaping the biotechnology landscape and creating unprecedented growth opportunities. The primary driver stems from the exponential growth in gene therapy development, with numerous clinical trials advancing through regulatory pipelines and receiving approvals from agencies like the USFDA and EMA, creating substantial demand for high-quality therapeutic DNA products. The COVID-19 pandemic significantly accelerated market growth by highlighting the critical importance of rapid vaccine development and manufacturing capabilities, particularly for mRNA vaccines that require sophisticated DNA templates and plasmids for production. Rising investments in synthetic biology and genetic engineering research by both private and public sectors are driving demand for custom DNA synthesis services and standardized DNA components. However, the market faces notable restraints including stringent regulatory frameworks that require extensive documentation, quality control measures, and compliance with Good Manufacturing Practice (GMP) standards, which significantly increase production costs and time-to-market. The high capital investment required for establishing state-of-the-art manufacturing facilities, coupled with the need for specialized skilled personnel and advanced equipment, creates barriers for new market entrants. Technical challenges related to maintaining DNA stability, ensuring purity levels, and scaling production processes from laboratory to commercial scale continue to pose operational constraints. Nevertheless, the market presents substantial opportunities driven by the expanding applications of DNA in emerging fields such as DNA data storage, agricultural biotechnology, and environmental remediation. The growing adoption of personalized medicine approaches is creating demand for patient-specific DNA constructs and custom manufacturing services. Technological advancements in automation, artificial intelligence-driven quality control, and novel synthesis methods are opening new avenues for cost reduction and efficiency improvements, while the increasing prevalence of genetic disorders globally continues to expand the addressable market for DNA-based therapeutic solutions.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global DNA manufacturing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Lonza Group, WuXi AppTec, GenScript Biotech, Thermo Fisher Scientific, Sigma-Aldrich (Merck Group), Integrated DNA Technologies, Eurofins Genomics, OriGene Technologies, Bluebird Bio, Sangamo Therapeutics, Cellectis, Caribou Biosciences, Editas Medicine, and Intellia Therapeutics.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global DNA manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global DNA manufacturing market.
Market Segmentation
- Type of DNA Insights (Revenue, USD Bn, 2021 - 2033)
- Synthetic DNA
- Oligonucleotide synthesis
- Custom DNA synthesis
- Plasmid DNA
- Gene DNA
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Oncology
- Gene Therapy
- Vaccine Development
- Immunotherapy
- Regenerative Medicine
- Neurodegenerative Diseases
- Cardiovascular Diseases
- Infectious Diseases
- Others (Rare Genetic Disorders)
- Technology Insights (Revenue, USD Bn, 2021 - 2033)
- PCR (Polymerase Chain Reaction)
- CRISPR/Cas9
- Next-Generation Sequencing (NGS)
- Gene Synthesis
- Others (Gene Editing and Modification)
- Grade Insights (Revenue, USD Bn, 2021 - 2033)
- GMP Grade (Good Manufacturing Practice)
- R and D Grade (Research and Development)
- Production Scale Insights (Revenue, USD Bn, 2021 - 2033)
- Commercial Scale Production
- Custom Scale Production
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations
- Others (Academic and Research Institutions, etc.)
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Lonza Group
- WuXi AppTec
- GenScript Biotech
- Thermo Fisher Scientific
- Sigma-Aldrich (Merck Group)
- Integrated DNA Technologies
- Eurofins Genomics
- OriGene Technologies
- Bluebird Bio
- Sangamo Therapeutics
- Cellectis
- Caribou Biosciences
- Editas Medicine
- Intellia Therapeutics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global DNA Manufacturing Market, By Type of DNA
- Global DNA Manufacturing Market, By Application
- Global DNA Manufacturing Market, By Technology
- Global DNA Manufacturing Market, By Grade
- Global DNA Manufacturing Market, By Production Scale
- Global DNA Manufacturing Market, By End User
- Global DNA Manufacturing Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global DNA Manufacturing Market, By Type of DNA, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Synthetic DNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Oligonucleotide synthesis
- Custom DNA synthesis
- Plasmid DNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Gene DNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global DNA Manufacturing Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Vaccine Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Regenerative Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Neurodegenerative Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Rare Genetic Disorders)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global DNA Manufacturing Market, By Technology, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- PCR (Polymerase Chain Reaction)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- CRISPR/Cas9
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Next-Generation Sequencing (NGS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Gene Synthesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Gene Editing and Modification)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global DNA Manufacturing Market, By Grade, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- GMP Grade (Good Manufacturing Practice)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- R and D Grade (Research and Development)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global DNA Manufacturing Market, By Production Scale, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Commercial Scale Production
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Custom Scale Production
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global DNA Manufacturing Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Academic and Research Institutions, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global DNA Manufacturing Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type of DNA, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Grade, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Production Scale, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type of DNA, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Grade, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Production Scale, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type of DNA, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Grade, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Production Scale, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type of DNA, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Grade, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Production Scale, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type of DNA, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Grade, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Production Scale, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type of DNA, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Grade, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Production Scale, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Lonza Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- WuXi AppTec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GenScript Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sigma-Aldrich (Merck Group)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Integrated DNA Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eurofins Genomics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- OriGene Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bluebird Bio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sangamo Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cellectis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Caribou Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Editas Medicine
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Intellia Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
